Clinical Trial Update: Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC [Phase 2]

View source ↗

Summary

Prospective Phase 2 trial assessing real-world outcomes of pembrolizumab in Black patients with non-small cell lung cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING